These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Farnsworth N; Fagan SP; Berger DH; Awad SS Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574 [TBL] [Abstract][Full Text] [Related]
6. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients. Choi DX; Jain AB; Orloff MS J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787 [TBL] [Abstract][Full Text] [Related]
10. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS]. Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599 [TBL] [Abstract][Full Text] [Related]
11. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. Membreno F; Baez AL; Pandula R; Walser E; Lau DT J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494 [TBL] [Abstract][Full Text] [Related]
12. Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results. Saad WE; Saad NE; Davies MG; Bozorgdadeh A; Orloff MS; Patel NC; Abt PL; Lee DE; Sahler LG; Kitanosono T; Sasson T; Waldman DL J Vasc Interv Radiol; 2006 Jun; 17(6):995-1002. PubMed ID: 16778233 [TBL] [Abstract][Full Text] [Related]
13. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219 [TBL] [Abstract][Full Text] [Related]
14. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397 [TBL] [Abstract][Full Text] [Related]
15. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Colombato L J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial. Chen L; Xiao T; Chen W; Long Q; Li R; Fang D; Wang R Liver Int; 2009 Aug; 29(7):1101-9. PubMed ID: 19386025 [TBL] [Abstract][Full Text] [Related]
17. Surgical shunts and TIPS for variceal decompression in the 1990s. Henderson JM; Nagle A; Curtas S; Geisinger M; Barnes D Surgery; 2000 Oct; 128(4):540-7. PubMed ID: 11015086 [TBL] [Abstract][Full Text] [Related]
20. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]